Home › NCT06565390

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER): A Randomized Clinical Trial

Who can join

22 Weeks – 6 Months · All sexes

Inclusion Criteria:

* Infants being discharged from the NICU
* Off all respiratory support (oxygen, CPAP, ventilator) before discharge home
* Gestational age ≥ 22 0/7 weeks' gestation at birth
* Parents/legal guardians have provided consent for enrollment

Exclusion Criteria:

* a major malformation, a neuromuscular condition that affects respiration or causes apnea, complex congenital heart disease and hemodynamically significant shunts, or terminal illness or decision to withhold or limit support.
* Infants being discharged from the neonatal intensive care unit (NICU) with a cardiorespiratory monitor or respiratory support are not eligible for inclusion.

About the study

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

What is being tested

• Babies in the Owlet monitor group (device)

Sponsor: University of Alabama at Birmingham · Participants: 700 · Started: Sep 11, 2025

Contact the study team

• Kimberly Armstead, BS · Phone: 205-934-0095
• Rachel Benz, MSN · Phone: 205-934-4680

Official record on ClinicalTrials.gov — NCT06565390

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.